Biography

Ming (Kyler) Lei joined NovaBridge as Chief Financial Officer in October 2025. Previously, from July 2022 to October 2025, Mr. Lei served as deputy general manager and head of capital markets at Sino Biopharmaceutical Limited (HKEX: 1177), where he was primarily responsible for corporate finance and capital markets. From June 2021 to July 2022, Mr. Lei served as head of investor relations at WuXi AppTec Co., Ltd. (SSE: 603259, HKEX: 2359), where he was responsible for investor relations and financial public relations. Mr. Lei served as an associate director at Daiwa Securities from June 2020 to June 2021, where he was the lead research analyst covering China’s healthcare industry, and an equity research analyst at Macquarie Group from June 2018 to June 2020. Mr. Lei earned a Master’s in Biotechnology from The Hong Kong University of Science and Technology and a Bachelor’s in Economics and Finance from the University of Hong Kong.